Piroxicam, Mitoxantrone, and Hypofractionated Radiation Therapy with Volumetric Modulated Arc Therapy for Treating Urinary Transitional Cell Carcinoma in a Dog: A Case Report |
Hwang, Tae-Sung
(Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University)
An, Soyon (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) Choi, Moon-Young (Yangsan S Animal Cancer Center) Huh, Chan (Yangsan S Animal Cancer Center) Song, Joong-Hyun (College of Veterinary Medicine, Chungnam National University) Jung, Dong-In (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) Lee, Hee Chun (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) |
1 | Marconato L, Nitzl DB, Melzer-Ruess KJ, Keller MA, Buchholz J. Chemotherapy and radiation therapy in 4 dogs with muscle-invasive transitional cell carcinoma of the urinary tract. Can Vet J 2012; 53: 875-879. |
2 | Norris AM, Laing EJ, Valli VE, Withrow SJ, Macy DW, Ogilvie GK, et al. Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985). J Vet Intern Med 1992; 6: 145-153. DOI |
3 | Rostom AY, Tahir S, Gershuny AR, Kandil A, Folkes A, White WF. Once weekly irradiation for carcinoma of the bladder. Int J Radiat Oncol Biol Phys 1996; 35: 289-292. DOI |
4 | Knapp DW, Henry CJ, Widmer WR, Tan KM, Moore GE, Ramos-Vara JA, et al. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 2013; 27: 126-133. DOI |
5 | Knapp DW, Richardson RC, Chan TC, Bottoms GD, Widmer WR, DeNicola DB, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994; 8: 273-278. DOI |
6 | Ladue T, Klein MK. Toxicity criteria of the veterinary radiation therapy oncology group. Vet Radiol Ultrasound 2001; 42: 475-476. DOI |
7 | Mutsaers AJ, Widmer WR, Knapp DW. Canine transitional cell carcinoma. J Vet Intern Med 2003; 17: 136-144. DOI |
8 | Henry CJ. Management of transitional cell carcinoma. Vet Clin North Am Small Anim Pract 2003; 33: 597-613. DOI |
9 | Evans MDC. Computerized treatment planning systems for external photon beam radiotherapy. In: Podgorsak EB, editor. Review of radiation oncology physics: a handbook for teachers and students. Vienna: IAEA. 2005: 387-406. |
10 | Farrelly J, Shi Q. Retrospective analysis of nonradiation complications in dogs undergoing radiation therapy. Vet Radiol Ultrasound 2018; 59: 116-123. DOI |
11 | Henry CJ, McCaw DL, Turnquist SE, Tyler JW, Bravo L, Sheafor S, et al. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clin Cancer Res 2003; 9: 906-911. |
12 | Knapp DW, Ramos-Vara JA, Moore GE, Dhawan D, Bonney PL, Young KE. Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development. ILAR J 2014; 55: 100-118. DOI |
13 | Choy K, Fidel J. Tolerability and tumor response of a novel low-dose palliative radiation therapy protocol in dogs with transitional cell carcinoma of the bladder and urethra. Vet Radiol Ultrasound 2016; 57: 341-351. DOI |
14 | Vassiliou V, Charalambous H. Curative intent versus palliative intent radiation oncology. In: Lutz S, Chow E, Hoskin P, editors. Radiation oncology in palliative cancer care. West Sussex: Wiley-Blackwe. 2013: 31-42. |
15 | Fulkerson CM, Knapp DW. Management of transitional cell carcinoma of the urinary bladder in dogs: a review. Vet J 2015; 205: 217-225. DOI |
16 | Knapp DW, Glickman NW, Denicola DB, Bonney PL, Lin TL, Glickman LT. Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer. Urol Oncol 2000; 5: 47-59. DOI |
17 | Poirier VJ, Forrest LJ, Adams WM, Vail DM. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study. J Am Anim Hosp Assoc 2004; 40: 131-136. DOI |
18 | Jose CC, Price A, Norman A, Jay G, Huddart R, Dearnaley DP, et al. Hypofractionated radiotherapy for patients with carcinoma of the bladder. Clin Oncol (R Coll Radiol) 1999; 11: 330-333. DOI |
19 | Nolan MW, Kogan L, Griffin LR, Custis JT, Harmon JF, Biller BJ, et al. Intensity-modulated and image-guided radiation therapy for treatment of genitourinary carcinomas in dogs. J Vet Intern Med 2012; 26: 987-995. DOI |
20 | Owen L. TNM classification of tumours in domestic animals. Geneva: World Health Organization. 1980. |
21 | Shaffer R, Vollans E, Vellani R, Welsh M, Moiseenko V, Goddard K. A radiotherapy planning study of RapidArc, intensity modulated radiotherapy, three-dimensional conformal radiotherapy, and parallel opposed beams in the treatment of pediatric retroperitoneal tumors. Pediatr Blood Cancer 2011; 56: 16-23. DOI |
22 | Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol 2011; 84: 967-996. DOI |